Fresh Tracks stops drug pipeline to save mon­ey as it keeps look­ing for an ex­it

Fresh Tracks Ther­a­peu­tics has hit pause on its drug de­vel­op­ment pipeline to save cap­i­tal re­sources and fig­ure out its ex­it strat­e­gy.

The re­search in­ter­rup­tion in­cludes …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER